When was Molecule founded?

Molecule was founded in 2018 and raised its 1st funding round 4 years after it was founded.

Where is Molecule located?

Molecule is headquartered in Berlin, Germany.

Who is the current CEO of Molecule?

Paul Kohlhaas of Molecule. They have also founded 1 company.

How many employees does Molecule have?

As of Sep 30, 2026, the latest employee count at Molecule is 24.

Is Molecule a funded company?

Molecule is a funded company, having raised a total of $***** in its 1st and only funding round, a Seed round on Jun 27, 2022.

When was the latest funding round of Molecule?

Molecule's latest funding was a $***** Seed round on Jun 27, 2022, with participation from 20 investors.

Where does Molecule rank among its competitors?

Molecule ranks 4th amongst 27 active competitors, of which 6 are funded. It stands 2nd in terms of total funding among its competitors. The most recent competitor to raise funding was Techspert, which secured $6.75M in Feb, 2026.

Who are the top competitors of Molecule?

Molecule's top competitors include Techspert, Collabrix and The Contract Network. Among them, Techspert secured the most recent funding round in February, 2026.

Molecule - 2026 Company Profile, Team, Funding & Competitors

Molecule is a seed company based in Berlin (Germany), founded in 2018 by Tyler Golato, Paul Kohlhaas and Titian Steiger. It operates as a Platform where drug development researchers and investors collaborate to invent therapeutics. Molecule has raised $12.7M in funding from Northpond Ventures. The company has 27 active competitors, including 6 funded and 2 that have exited. Its top competitors include companies like Techspert, Collabrix and The Contract Network.

Company Details

Platform where drug development researchers and investors collaborate to invent therapeutics. It offers a web3 marketplace for biotech DAOs that connects academics and biotech companies for research-related IP.

Website: molecule.xyz
Social
Email ID: *****@molecule.to

Key Metrics

Founded Year

2018

Location

Berlin, Germany

Stage

Seed

Total Funding

$12.7M in 1 round

Latest Funding Round

Seed, Jun 27, 2022, $*****

Investors

Northpond Ventures & 23 more

Ranked

4^th among 27 active competitors

Employee Count

24 as on Sep 30, 2026

Similar Companies

Techspert & 29 more

View Molecule's full profile

Molecule has raised a total funding of $12.7M over 1 round. Its latest funding round was a Seed round on Jun 27, 2022 for $*****. 20 investors participated in its latest round. Molecule has 23 institutional investors and 1 angel investor.

Here is the list of recent funding rounds of Molecule:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jun 27, 2022	3347721	Seed	6262465	6868709	5714363	5524990

Access funding benchmarks and valuations. Sign up today!

View details of Molecule's funding rounds and investors

The founders of Molecule are Tyler Golato, Paul Kohlhaas and Titian Steiger. Paul Kohlhaas is the CEO of Molecule.

Here are the details of Molecule's key team members:

Tyler Golato: Co-Founder of Molecule and founder of 2 other companies, VitaDAO and Molecule.
Paul Kohlhaas: Co-Founder & CEO of Molecule and founder of 2 other companies, Molecule and Linum Labs.
Contact Info: 2 email addresses
Titian Steiger: Co-Founder of Molecule and founder of 1 other company.

View details of Molecule's Founder profiles and Board Members

Molecule's employee count trend

Molecule has 24 employees as of Sep 26. Here is Molecule's employee count trend over the years:

Uncover Molecule's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Molecule include Techspert, Collabrix and The Contract Network. Here is the list of Top 10 competitors of Molecule, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Techspert 2016, London (United Kingdom), Series B	Leading expert network for healthcare and life sciences	$24.9M	Nauta Capital, BGF & 14 others	63/100
2nd	Collabrix 2018, Houston (United States), Series A	Developer of digital platforms for supply chain collaboration and orchestration	-	ThinKuvate, Five Gardens & 3 others	48/100
3rd	The Contract Network 2021, Atlanta (United States), Acquired	Digital collaborative platform for clinical trials	$6.87M	TVP, Toba Capital & 3 others	46/100
4th	Molecule 2018, Berlin (Germany), Seed	Platform where drug development researchers and investors collaborate to invent therapeutics	$12.7M	Northpond Ventures, Boost VC & 22 others	44/100
5th	Vaniam Group 2007, Chicago (United States), Unfunded	Provider of consulting services for the manufacturing of medical devices	-	-	44/100
6th	BioNeex 2018, Berlin (Germany), Seed	Provider of SaaS-based drug licensing and drug candidate partnership exchange platform for the biopharma industry	$500K	-	43/100
7th	XO Life 2016, Munich (Germany), Series A	Provider of digital platform for pharmaceutical and medical device treatment support	$10.1M	Seedlink Tech, Aescuvest & 12 others	41/100
8th	Inpart 2010, Lyon (France), Seed	Platform connecting scientific decision makers with research, assets, and expertise	-	Thecarlylegroup.fr, The Carlyle Group & 1 others	40/100
9th	Nucleo 2020, Prague (Czech Republic), Unfunded	Digital platform connecting professionals and businesses in the life sciences industry	-	-	34/100
10th	SciTok 2018, San Francisco (United States), Funding Raised	Provider of video platform and social network for researchers	-	Soma Capital	27/100